Insulin pumps backed by NICE

Insulin pump therapy has been approved for patients with type-1 diabetes, according to preliminary NICE guidance.

Both children and adults with difficult to control type-1 diabetes could be eligible for continuous subcutaneous insulin infusion (CSII).

Under-11s can be given the treatment if multiple-dose insulin (MDI) therapy is inappropriate.

Older patients are eligible for CSII if they find it impossible to maintain a HbA1c of 8.5 per cent or less using MDI or they suffer from recurrent and unpredictable hypoglycaemic events, says NICE.

CSII uses an external pump to continuously deliver insulin to the patient. It can be programmed to ensure insulin is delivered at higher rates at meal times, or has different basal rates in the day or night.

The NICE appraisal committee says evidence shows CSII has a valuable effect on HbA1c levels and can reduce the rate of hypoglycaemic episodes.

CSII can only be initiated by specialist teams, says NICE.

Professor Mike Kirby, a GP with an interest in diabetes, said: 'It's good news. It's been a battle to get funding for this in the past.'

Therapy eligibility

  • Type-1 diabetes patients.
  • Under-11s who have difficulty using MDI.
  • Over-11s and adults who have HbA1c >8.5 per cent.
  • Over-11s and adults with recurrent hypoglycaemia.

rachel.liddle@haymarket.com

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

MPs demand urgent action on NHS backlog and routine COVID-19 tests for staff

MPs demand urgent action on NHS backlog and routine COVID-19 tests for staff

MPs have demanded urgent action to prevent avoidable harm to patients from the NHS...

Freeze QOF and deliver COVID cash or second wave will overwhelm GPs, BMA warns

Freeze QOF and deliver COVID cash or second wave will overwhelm GPs, BMA warns

GP practices will be unable to cope with a second wave of COVID-19 unless urgent...

Reducing our practice's carbon footprint by appropriate inhaler prescribing

Reducing our practice's carbon footprint by appropriate inhaler prescribing

Dr Vasu Siva explains how her practice is aiming to cut its carbon emissions by targeting...

RCGP chair warns of 'significant problem' over flu vaccine supplies

RCGP chair warns of 'significant problem' over flu vaccine supplies

The NHS faces a 'significant problem' with flu vaccine supplies as it aims to cover...

GMC overhauls consent advice to improve patient involvement in decisions about care

GMC overhauls consent advice to improve patient involvement in decisions about care

The GMC has overhauled its guidance on patient consent - setting out seven key principles...

Government must show evidence behind PPE strategy, warns BMA

Government must show evidence behind PPE strategy, warns BMA

Chronic shortages of personal protective equipment (PPE) across the NHS during the...